Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitis

Jakob Theorell, Ruby Harrison, Robyn Williams, Matthew I. J. Raybould, Meng Zhao, Hannah Fox, Andrew Fower, Georgina Miller, Zoe Y. Wu, Eleanor Browne, Victor Mgbachi, Bo Sun, Rohini Mopuri, Ying Li, Patrick Waters, Charlotte M. Deane, Adam E. Handel, Mateusz Makuch, Sarosh R. IraniProceedings of the National Academy of Sciences 2024 · DOI

TL;DR

This study reveals that in autoimmune encephalitis (AE) targeting LGI1 and CASPR2, the cerebrospinal fluid (CSF) is dominated by highly specific, clonally expanded B cells that are already mature. These cells, primarily antibody-secreting cells (ASCs), show evidence of peripheral maturation rather than significant development within the CNS, suggesting that therapeutic strategies might be more effective if they target the periphery.

What Problem Does This Paper Address?

Autoimmune encephalitis (AE) is a debilitating neurological condition where the body's immune system mistakenly attacks its own brain. Two common forms, mediated by antibodies against LGI1 and CASPR2, often lead to persistent neurological deficits and relapses even with treatment. A key question in understanding AE pathogenesis is where the autoantibodies that attack the central nervous system (CNS) are produced and how the B cells that generate them mature. While intrathecal (within the CNS) antibody production is known, it's unclear whether B cells mature and diversify within the CNS itself or if they are primarily generated and matured in the periphery before migrating to the CNS. This knowledge gap hinders the development of more targeted and effective therapies.

Methods

The researchers employed a multi-faceted single-cell approach. They collected cerebrospinal fluid (CSF) from three AE patients and used fluorescence-activated cell sorting (FACS) to isolate individual B cells and antibody-secreting cells (ASCs). These cells underwent single-cell RNA sequencing (scRNA-seq) to capture their full transcriptome and B cell receptor (BCR) sequences. Cognate heavy and light chain pairs were then assembled to express these BCRs as monoclonal antibodies (mAbs). These mAbs were tested for binding to LGI1 and CASPR2 using cell-based assays and, if negative, against broader CNS antigens via immunohistochemistry and live neuron staining. To understand B cell maturation, they compared the genetic sequences of BCRs from the peripheral "founder" clone (unmutated common ancestor, UCA) to those found within the CSF, analyzing mutations and affinity. T cell receptor (TCR) clonality in the CSF was also assessed.

Datasets

The study utilized CSF samples from three patients with LGI1 or CASPR2 antibody encephalitis. For comparative analysis of BCR "privateness," they referenced the Observed Antibody Space (OAS) database, which contains over 2 billion natural human heavy chain sequences. They also referenced a dataset of public SARS-CoV-2 ASC-derived BCRs and healthy control CSF data for T cell clonality comparisons. No new benchmark datasets were introduced.

Key Insights and Ideas

  • CSF is a "mature B cell factory": The most striking finding is the exceptionally high frequency of autoantigen-specific B cells within the CSF, particularly in larger clonal expansions (up to 100% specificity in clones with ≥4 members). This suggests a highly targeted and active B cell population within the CNS.
  • Peripheral maturation is dominant: Despite evidence of differentiation within the CSF (e.g., from plasmablasts to plasma cells), these autoantigen-reactive cells show minimal evidence of intrathecal affinity maturation or somatic hypermutation. This strongly implies that their critical maturation processes, including affinity enhancement, largely occur outside the CNS.
  • "Precision medicine" potential: The identification of specific autoantigen-reactive ASCs in the CSF opens avenues for highly targeted therapies, though the dominant peripheral maturation suggests targeting peripheral immune compartments might be more impactful.
  • Limited CNS T cell help: The low clonality observed in CSF T cells suggests that these autoantigen-reactive B cell expansions in the CNS may not heavily rely on T cell help for their development or maintenance within the CNS.

Key Results

  • Out of 381 cognate-paired IgG BCRs isolated, 166 were expressed as mAbs.
  • 62% of mAbs from singleton BCRs reacted with LGI1 or CASPR2, rising to 100% in clonal groups with ≥4 members.
  • Autoantigen reactivity was significantly enriched in antibody-secreting cells (ASCs) compared to other B cell populations (P < 0.0001).
  • LGI1- and CASPR2-reactive B cells and ASCs showed more differentiated gene expression profiles than their unreactive counterparts.
  • While differentiation was observed within the CSF, autoantigen-reactive cells acquired few intrathecal mutations and showed minimal variation in autoantigen affinities within clonal expansions.
  • Comparisons between germline-encoded BCRs (UCAs) and their intrathecal founders revealed significant gains in affinity and mutational distances, pointing to peripheral maturation.
  • CSF T cell receptor clonality was low (2-11% of CD4+ T cells) compared to healthy controls.

Limitations and Future Work

The authors acknowledge several limitations:

  • Small sample size: The study involved only three patients. Larger cohorts are needed to confirm findings and explore potential differences between LGI1 and CASPR2 AE.
  • Lack of peripheral B cell analysis: While UCAs were used to infer peripheral contributions, direct analysis of autoantigen-reactive B cells from peripheral blood or bone marrow was not performed, which would be technically challenging due to their likely low frequency and affinity.
  • Limited memory B cell observation: Few autoantigen-specific memory B cells were observed in the CSF, making it difficult to infer B cell trajectories within the CNS. The authors hypothesize that memory B cells may rapidly differentiate into ASCs in the antigen-rich CNS environment.
  • IgG subclass limitation: The study focused on IgG4, and further IgG recombination beyond this subclass could not be assessed.

Future work should focus on larger patient cohorts, direct peripheral B cell analysis, and exploring the role of peripheral germinal centers (e.g., in deep cervical lymph nodes) as the primary sites of maturation for these pathogenic B cells. Understanding the mechanisms driving these peripheral expansions and how they are regulated could lead to more effective therapeutic interventions.

Summary updated

Abstract

Intrathecal synthesis of central nervous system (CNS)-reactive autoantibodies is observed across patients with autoimmune encephalitis (AE), who show multiple residual neurobehavioral deficits and relapses despite immunotherapies. We leveraged two common forms of AE, mediated by leucine-rich glioma inactivated-1 (LGI1) and contactin-associated protein-like 2 (CASPR2) antibodies, as human models to comprehensively reconstruct and profile cerebrospinal fluid (CSF) B cell receptor (BCR) characteristics. We hypothesized that the resultant observations would both inform the observed therapeutic gap and determine the contribution of intrathecal maturation to pathogenic B cell lineages. From the CSF of three patients, 381 cognate-paired IgG BCRs were isolated by cell sorting and scRNA-seq, and 166 expressed as monoclonal antibodies (mAbs). Sixty-two percent of mAbs from singleton BCRs reacted with either LGI1 or CASPR2 and, strikingly, this rose to 100% of cells in clonal groups with ≥4 members. These autoantigen-reactivities were more concentrated within antibody-secreting cells (ASCs) versus B cells (<i>P</i> < 0.0001), and both these cell types were more differentiated than LGI1- and CASPR2-unreactive counterparts. Despite greater differentiation, autoantigen-reactive cells had acquired few mutations intrathecally and showed minimal variation in autoantigen affinities within clonal expansions. Also, limited CSF T cell receptor clonality was observed. In contrast, a comparison of germline-encoded BCRs versus the founder intrathecal clone revealed marked gains in both affinity and mutational distances (<i>P</i> = 0.004 and <i>P</i> < 0.0001, respectively). Taken together, in patients with LGI1 and CASPR2 antibody encephalitis, our results identify CSF as a compartment with a remarkably high frequency of clonally expanded autoantigen-reactive ASCs whose BCR maturity appears dominantly acquired outside the CNS.
BibTeX
@inproceedings{theorell2024ultrahigh,
  author = {Jakob Theorell and Ruby Harrison and Robyn Williams and Matthew I. J. Raybould and Meng Zhao and Hannah Fox and Andrew Fower and Georgina Miller and Zoe Y. Wu and Eleanor Browne and Victor Mgbachi and Bo Sun and Rohini Mopuri and Ying Li and Patrick Waters and Charlotte M. Deane and Adam E. Handel and Mateusz Makuch and Sarosh R. Irani},
  title = {{Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitis}},
  booktitle = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2311049121},
}
Figure